Dr. Philip J. Wyatt Technology Transfer Award Grant

The Dr. Philip J. Wyatt Technology Transfer Award, established in 2025, recognizes Sigma Xi members for their contributions to the commercialization of scientific research. Named after Dr. Wyatt, a leader in innovative light scattering technology, this award supports bridging the gap between research and market viability. Eligible applicants can receive funding for developing marketable products, protecting intellectual property, and enhancing technology, ensuring advancements in health and economic betterment for society.

About Dr. Philip J. Wyatt
Dr. Wyatt is a renowned physicist, businessman, and long-time Sigma Xi member. His company, Wyatt Technologies, is the recognized leader in innovative light scattering instruments within the pharmaceutical and biotech industry, government labs, medical device industry, academic centers, and companies developing chemicals, cosmetics, food, and beverages.
Philip J. Wyatt Technology Transfer Award supports the commercialization aspects of Sigma Xi members’ research, aiding in bridging the gap between research and commercial viability. Commercialization is the process of transforming research discoveries into marketable products or services, involving steps like patenting, industry collaboration, and strategy development to bring innovations to consumers.
The objective of this award is to promote the commercialization of scientific research for health, security, or economic betterment of society.
Approved applications of funds include but are not limited to:

• Developing the technology into a product or service that can be sold in the market
• Further development of the technology
• Protecting intellectual property with patents and copyrights
• Regulatory approvals
• Sales and marketing
• Support and training

Eligibility

Open to any active (dues-paying) Sigma Xi member at the time of the nomination.
Self-nominations are accepted.
You must be a member of this organization to apply for this award - become a member.